ScienceGermany1 sourcesNeutral

Gilead buying Tubulis and its ADCs in $5B takeover bid

German company Tubulis GmbH, which emerged with a $12.3 million series A round and a next-generation antibody-drug conjugate (ADC) platform about six years ago, has commanded up to $5 billion in a buyout offer from Gilead Sciences Inc.

karen carey

via Bioworld

April 7, 2026 | 4:00 PM UTCUpdated 3h ago

Share Read original

Read the full article at Bioworld →

Gilead buying Tubulis and its ADCs in $5B takeover bid

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Bioworld

NewsDataDE

Comments

0 comments

Be respectful and constructive.

Loading comments...

Gilead buying Tubulis and its ADCs in $5B takeover bid

Source Verification

Comments

Ghana Plans Second Paragliding Site in Volta Region by 2027

This NZ winter could get properly cold

Related Articles

A carbon Catch-22: The risks of racing into climate change solutions

The mathematically correct way to slice a pizza

King Charles 'cannot bear' to be in the same room as 1 pet